Suppr超能文献

用于评估药物清除率和药物相互作用的人肝细胞与基质细胞的微图案共培养

Micropatterned Co-Cultures of Human Hepatocytes and Stromal Cells for the Assessment of Drug Clearance and Drug-Drug Interactions.

作者信息

Lin Christine, Khetani Salman R

机构信息

School of Biomedical Engineering, Colorado State University, Fort Collins, Colorado.

Department of Bioengineering, University of Illinois at Chicago, Chicago, Illinois.

出版信息

Curr Protoc Toxicol. 2017 May 2;72:14.17.1-14.17.23. doi: 10.1002/cptx.23.

Abstract

Drug clearance rates from the body can determine drug exposure that can affect efficacy or toxicity. Thus, accurate prediction of drug clearance during preclinical development can help guide dose selection in humans, but animal testing is not always predictive of human outcomes. Because hepatic drug metabolism is a rate-limiting step in the overall clearance of many drugs, primary human hepatocytes (PHHs) in suspension cultures or monolayers are used for drug clearance predictions. Yet, the precipitous decline in drug metabolism capacity can lead to significant underestimation of clearance rates, particularly for low turnover compounds that have desirable one-pill-a-day dosing regimens. In contrast, micropatterned co-cultures (MPCCs) of PHHs and fibroblasts display phenotypic stability for several weeks and can help mitigate the limitations of conventional cultures. Here, we describe protocols to create and use MPCCs for drug clearance predictions, and for modeling clinically-relevant drug-drug interactions that can affect drug clearance. © 2017 by John Wiley & Sons, Inc.

摘要

药物从体内的清除率可决定药物暴露量,而药物暴露量会影响疗效或毒性。因此,在临床前开发过程中准确预测药物清除率有助于指导人体剂量选择,但动物试验并不总是能够预测人体结果。由于肝脏药物代谢是许多药物整体清除过程中的限速步骤,悬浮培养或单层培养的原代人肝细胞(PHH)被用于药物清除率预测。然而,药物代谢能力的急剧下降可能导致清除率被显著低估,尤其是对于那些具有理想的每日一片给药方案的低周转率化合物。相比之下,PHH与成纤维细胞的微图案共培养物(MPCC)在数周内表现出表型稳定性,有助于缓解传统培养方法的局限性。在此我们描述创建并使用MPCC进行药物清除率预测以及对可能影响药物清除率的临床相关药物相互作用进行建模的方案。© 2017约翰威立国际出版公司

相似文献

2
Prediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes.
Drug Metab Dispos. 2016 Jan;44(1):127-36. doi: 10.1124/dmd.115.066027. Epub 2015 Oct 9.
3
Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.
Integr Biol (Camb). 2017 Aug 14;9(8):662-677. doi: 10.1039/c7ib00027h.
4
Intermittent Starvation Extends the Functional Lifetime of Primary Human Hepatocyte Cultures.
Toxicol Sci. 2020 Apr 1;174(2):266-277. doi: 10.1093/toxsci/kfaa003.
7
Comparison of Human Long-Term Liver Models for Clearance Prediction of Slowly Metabolized Compounds.
Drug Metab Dispos. 2024 May 16;52(6):539-547. doi: 10.1124/dmd.123.001638.
9
Advances in Engineered Human Liver Platforms for Drug Metabolism Studies.
Drug Metab Dispos. 2018 Nov;46(11):1626-1637. doi: 10.1124/dmd.118.083295. Epub 2018 Aug 22.

引用本文的文献

2
Long-term HBV infection of engineered cultures of induced pluripotent stem cell-derived hepatocytes.
Hepatol Commun. 2024 Jul 31;8(8). doi: 10.1097/HC9.0000000000000506. eCollection 2024 Aug 1.
3
Pharmacokinetics-Pharmacodynamics Modeling for Evaluating Drug-Drug Interactions in Polypharmacy: Development and Challenges.
Clin Pharmacokinet. 2024 Jul;63(7):919-944. doi: 10.1007/s40262-024-01391-2. Epub 2024 Jun 18.
4
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.
Oncogene. 2022 Apr;41(14):2054-2068. doi: 10.1038/s41388-022-02209-w. Epub 2022 Feb 17.
5
Co-culture with mouse embryonic fibroblasts improves maintenance of metabolic function of human small hepatocyte progenitor cells.
Curr Res Toxicol. 2020 Aug 26;1:70-84. doi: 10.1016/j.crtox.2020.08.001. eCollection 2020 Jun 10.
6
Simple, Affordable, and Modular Patterning of Cells using DNA.
J Vis Exp. 2021 Feb 24(168). doi: 10.3791/61937.
9
Emerging trends in modeling human liver disease .
APL Bioeng. 2019 Dec 24;3(4):040902. doi: 10.1063/1.5119090. eCollection 2019 Dec.
10
Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.
Clin Pharmacol Ther. 2019 Jul;106(1):139-147. doi: 10.1002/cpt.1458. Epub 2019 Jun 4.

本文引用的文献

2
Prediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes.
Drug Metab Dispos. 2016 Jan;44(1):127-36. doi: 10.1124/dmd.115.066027. Epub 2015 Oct 9.
5
Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
Toxicol Sci. 2015 Jun;145(2):252-62. doi: 10.1093/toxsci/kfv048. Epub 2015 Feb 24.
6
Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver.
Tissue Eng Part C Methods. 2015 Jul;21(7):716-25. doi: 10.1089/ten.TEC.2014.0512. Epub 2015 Jan 30.
7
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12193-8. doi: 10.1073/pnas.1412631111. Epub 2014 Aug 4.
9
Evaluation of a liver microfluidic biochip to predict in vivo clearances of seven drugs in rats.
J Pharm Sci. 2014 Feb;103(2):706-18. doi: 10.1002/jps.23796. Epub 2013 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验